Geovax Labs Inc. (GOVX)
Market Closed
3 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 0300
-0.07
-3.33%
$
2.56M Market Cap
- P/E Ratio
- Div Yield
621,949 Volume
0 Eps
$ 2.1
Previous Close Investors:
Want to track GOVX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
Geovax Labs (NASDAQ: GOVX ) stock is jumping on Tuesday as investors in GOVX prepare for a catalyst on July 18. That's when Geovax Labs will hold a presentation at the Emerging Growth Conference.
Investorplace | 1 year ago
Why Is GeoVax (GOVX) Stock Up 110% Today?
Biotechnology specialist GeoVax (NASDAQ: GOVX ) — which focuses on developing immunotherapies and vaccines against cancers and infectious diseases — just announced a partnership with global clinical research organization Allucent. The main purpose behind the agreement is to conduct a Phase 2b clinical trial of GeoVax's next-generation Covid-19 vaccine.
Investorplace | 1 year ago
